Perampanel

CHEMBL1214124 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

349.4 g/mol

LogP

3.4

Phase

4

This anti-seizure medication treats epilepsy by blocking brain receptors that trigger seizure activity.

Moleküler Ağırlık

349,4000 g/mol

LogP

3,40

TPSA

57,00 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Parkinson's Disease Epilepsy Migraine Bipolar Disorder Stroke Major Depressive Disorder

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

N#Cc1ccccc1-c1cc(-c2ccccn2)cn(-c2ccccc2)c1=O

InChI

InChI=1S/C23H15N3O/c24-15-17-8-4-5-11-20(17)21-14-18(22-12-6-7-13-25-22)16-26(23(21)27)19-9-2-1-3-10-19/h1-14,16H

Molecular Formula

C23H15N3O

HBD / HBA

- / 3

Döndürülebilir Bağlar

3

Ağır Atomlar

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This anti-seizure medication treats epilepsy by blocking brain receptors that trigger seizure activity.

Yes, Perampanel is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1214124. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 9924495. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Perampanel PillFYI'da

Yapı

Hızlı Veriler

Formül: C23H15N3O
Eş Anlamlılar: 1

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.